FDA Approved: SYNTHROID — Supplemental Application (AbbVie Inc.)

View source ↗

Summary

The FDA approved a supplemental application for SYNTHROID (levothyroxine sodium) submitted by AbbVie, resulting in a label change for the product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypothyroidism

Drugs mentioned

• SYNTHROID (LEVOTHYROXINE SODIUM)

Snippet

SUPPL AP for SYNTHROID (LEVOTHYROXINE SODIUM)